Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: December 12, 2025
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing.
Journal: Cancers
Published: August 21, 2025
Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective Analysis.
Journal: Clinical genitourinary cancer
Published: August 21, 2025
ALK-Rearranged renal neoplasms: update on an institutional cohort.
Journal: Virchows Archiv : an international journal of pathology
Published: July 21, 2025
Lower SYNJ2BP Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis.
Journal: Cancer genomics & proteomics
Published: June 28, 2025
Analysis of Peroxisomal ABCD3 Transporter as a Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Analysis of Peroxisomal ABCD3 Transporter as a Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Journal: Cancer genomics & proteomics
Published: April 10, 2025
Outcomes for [177Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer.
Journal: European urology oncology
Published: March 12, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy.
Journal: Annals of translational medicine
Published: October 24, 2024
Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy.
Journal: Journal of blood medicine
Published: August 17, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu-PSMA-617.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 25, 2024
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Journal: Cancer treatment reviews
Published: March 20, 2024
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Journal: Prostate cancer and prostatic diseases
Published: September 24, 2023
Last Updated: 09/26/2026